NasdaqCM - Nasdaq Real Time Price USD
60 Degrees Pharmaceuticals, Inc. (SXTP)
2.4092
+0.0192
+(0.83%)
As of 11:03:51 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 63.82k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MILLER TYRONE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
| DOW GEOFFREY S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 17, 2025 |
| XU CHERYL Director | Purchase at price 1.45 - 1.85 per share. | Direct | 21,400 | Dec 16, 2024 |
| DOW GEOFFREY S Chief Executive Officer | Purchase at price 1.11 - 1.27 per share. | Direct | 89,755 | Dec 9, 2024 |
| DOW GEOFFREY S Chief Executive Officer | Purchase at price 0.90 - 0.92 per share. | Direct | 6,367 | Nov 21, 2024 |
| XU CHERYL Director | Purchase at price 1.70 per share. | Direct | 8,500 | Aug 27, 2024 |
| FIELD PAUL Director | Conversion of Exercise of derivative security at price 0.22 per share. | Direct | 892 | May 16, 2024 |
| XU CHERYL Director | Conversion of Exercise of derivative security at price 0.22 per share. | Direct | 446 | May 16, 2024 |
| TOOVEY STEPHEN Director | Stock Award(Grant) at price 0.22 per share. | Direct | 892 | May 16, 2024 |
| TOOVEY STEPHEN Director | Conversion of Exercise of derivative security at price 0.06 per share. | Direct | 228 | May 16, 2024 |
| ALLEN CHARLES W Director | -- | Direct | -- | May 16, 2024 |
| DOW GEOFFREY S Chief Executive Officer | Conversion of Exercise of derivative security at price 0.22 - 0.27 per share. | Direct | 21,933 | May 16, 2024 |
| MILLER TYRONE Chief Financial Officer | Stock Award(Grant) at price 0.22 - 0.27 per share. | Direct | 19,353 | May 16, 2024 |
| MILLER TYRONE Chief Financial Officer | Conversion of Exercise of derivative security at price 0.06 per share. | Direct | 3,420 | Apr 12, 2024 |
| XU CHERYL Director | -- | Direct | -- | Feb 1, 2024 |
| XU CHERYL Director | Purchase at price 0.38 per share. | Direct | 75,000 | Jan 31, 2024 |
| DOW GEOFFREY S Chief Executive Officer | Purchase at price 0.38 per share. | Direct | 9,740 | Jan 31, 2024 |
| KNIGHT THERAPEUTICS, INC. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 4.74 per share. | Indirect | 216,182 | Jul 28, 2023 |
Related Tickers
OSRH OSR Holdings, Inc.
1.2800
+2.40%
SLXN Silexion Therapeutics Corp
0.9705
-0.09%
ARTL Artelo Biosciences, Inc.
1.0071
-1.26%
ENSC Ensysce Biosciences, Inc.
2.1350
-1.61%
CHRO Channel Therapeutics Corporation
1.0476
-4.76%
CERO CERo Therapeutics Holdings, Inc.
0.6200
-4.64%
IBO Impact BioMedical Inc.
0.5578
+1.51%
APVO Aptevo Therapeutics Inc.
0.3349
-1.50%
VRAX Virax Biolabs Group Limited
1.0550
+0.48%
CMMB Chemomab Therapeutics Ltd.
1.2550
+0.40%